We have previously shown that down regulation of PrKD1 is associated with prostate cancer progression through several molecular mechanisms [2, 8, 13, 23, 24] including nuclear translocation of beta-catenin and by influencing AR transcriptional activity. The gene discussed is AR; the disease is prostate carcinoma.